The Predictive Value of Indocyanine Green Clearance in Future Liver Remnant for Posthepatectomy Liver Failure Following Hepatectomy with Extrahepatic Bile Duct Resection

World Journal of Surgery

Volumn 40, Issue 6, 2016, Pages 1440-1447

  Yokoyama, Yukihiro ^a   Ebata, Tomoki ^a   Igami, Tsuyoshi ^a   Sugawara, Gen ^a   Mizuno, Takashi ^a   Yamaguchi, Junpei ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; INDOCYANINE GREEN;

ADULT; ADVERSE EFFECTS; AGED; BILE DUCT NEOPLASMS; BLOOD; CHOLANGIOCARCINOMA; EXTRAHEPATIC BILE DUCT; FEMALE; HUMAN; LIVER FAILURE; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BLOOD LOSS, SURGICAL; CHOLANGIOCARCINOMA; COLORING AGENTS; FEMALE; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER FAILURE; MALE; MIDDLE AGED; OPERATIVE TIME; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84959140253     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-016-3441-1     Document Type: Article

References (27)

1. Natsume S, Ebata T, Yokoyama Y et al (2012) Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg 255:754-762
2. Nagino M, Kamiya J, Arai T et al (2006) "Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg 243:28-32
3. Ebata T, Kosuge T, Hirano S et al (2014) Proposal to modify the international union against cancer staging system for perihilar cholangiocarcinomas. Br J Surg 101:79-88
4. Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364-372
5. Yokoyama Y, Nishio H, Ebata T et al (2010) Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 97:1260-1268
6. Igami T, Nishio H, Ebata T et al (2010) Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Sci 17:449-454
7. Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77-83
8. Ebata T, Yokoyama Y, Igami T et al (2012) Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg 29:23-29
9. Nagino M, Nimura Y, Kamiya J et al (1995) Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 117:677-681
10. Nagino M, Nimura Y, Kamiya J et al (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200:559-563
11. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713-724
12. Rahbari NN, Reissfelder C, Koch M et al (2011) The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol 18:3640-3649
13. Mangram AJ, Horan TC, Pearson ML et al (1999) Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27:97-132; quiz 133-134; discussion 196
14. Kokudo N, Vera DR, Tada K et al (2002) Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26:1342-1347
15. Nanashima A, Yamaguchi H, Shibasaki S et al (2001) Measurement of serum hyaluronic acid level during the perioperative period of liver resection for evaluation of functional liver reserve. J Gastroenterol Hepatol 16:1158-1163
16. Lee SG, Hwang S (2005) How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg 12:38-43
17. Imamura H, Shimada R, Kubota M et al (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29:1099-1105
18. Yokoyama Y, Nagino M, Oda K et al (2008) Sex dimorphism in the outcome of preoperative right portal vein embolization. Arch Surg 143:254-259; discussion 259
19. Yokoyama Y, Ebata T, Igami T et al (2014) The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery
20. Abdalla EK, Denys A, Chevalier P et al (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery 135:404-410
21. Shirabe K, Shimada M, Gion T et al (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188:304-309
22. Guglielmi A, Ruzzenente A, Conci S et al (2012) How much remnant is enough in liver resection? Dig Surg 29:6-17
23. Nonami T, Nakao A, Kurokawa T et al (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669-1672
24. Hemming AW, Scudamore CH, Shackleton CR et al (1992) Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163:515-518
25. Kasai Y, Hatano E, Iguchi K et al (2013) Prediction of the remnant liver hypertrophy ratio after preoperative portal vein embolization. Eur Surg Res 51:129-137
26. Ohkura Y, Mizuno S, Kishiwada M et al (2014) Benefit of technetium-99 m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res 44:E118-128
27. Hwang S, Ha TY, Song GW et al (2015) Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and liver volumetry combined with standard liver volume. J Gastrointest Surg 19:1305-1314